When dendritic cells phagocytose tumor cells, the STING pathway is triggered by tumor cell-derived DNA, which then induces type I IFN and promotes antigen presentation and activation of antigen-specific T cells for eliminating tumors [6]. This evidence concerns the gene STING1 and neoplasm.